Cleared Traditional

Kurin Blood Culture Collection Set with Kurin Lock Technology (K220677) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K220677 · Kurin, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2023
Decision
416d
Days
Class 2
Risk

K220677 is an FDA 510(k) clearance for the Kurin Blood Culture Collection Set with Kurin Lock Technology. Classified as Tubes, Vials, Systems, Serum Separators, Blood Collection (product code JKA), Class II - Special Controls.

Submitted by Kurin, Inc. (San Diego, US). The FDA issued a Cleared decision on April 28, 2023 after a review of 416 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 862.1675 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Kurin, Inc. devices

Submission Details

510(k) Number K220677 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 08, 2022
Decision Date April 28, 2023
Days to Decision 416 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
287d slower than avg
Panel avg: 129d · This submission: 416d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JKA Tubes, Vials, Systems, Serum Separators, Blood Collection
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1675
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - JKA Tubes, Vials, Systems, Serum Separators, Blood Collection

All 100
Devices cleared under the same product code (JKA) and FDA review panel - the closest regulatory comparables to K220677.
Blood Collection Set, Blood Collection Set with Holder, Safety Blood Collection Set, Safety Blood Collection Set with Holder, Blood
K230080 · Yangzhou Medline Industry, Co., Ltd. · Jul 2023
Unistik® ShieldLock, Unistik VacuFlip
K223854 · Owen Mumford, Ltd. · Jun 2023
K-SHIELD Zen (Model Numbers: PBMH/ PBMA/ PBM)
K230408 · Sb-Kawasumi Laboratories, Inc. · Jun 2023
BD Vacutainer® Push Button Blood Collection Set, BD Vacutainer® Push Button Blood Collection Set with Pre-Attached Holder
K220212 · Becton, Dickinson and Company · Mar 2023
Blood Collection Needle (with/without Needle Holder)
K223323 · Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. · Mar 2023
BD Vacutainer® Luer-Lok™ Access Device, BD Vacutainer® Blood Transfer Device
K222478 · Becton, Dickinson and Company · Mar 2023